DTL
OKUR

Dynamic Technology Lab’s OnKure Therapeutics OKUR Stock Holding History

Dynamic Technology Lab’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,271
Closed -$20K – 1489
2023
Q4 		$20K Buy
+1,271
New +$79.2K ﹤0.01% 989

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Dynamic Technology Lab's OKUR Position: Q1 2024 in Review

Dynamic Technology Lab sold out of OnKure Therapeutics (OKUR) in Q1 2024, closing a stake of 1,271 shares — an estimated $20K sold.

Dynamic Technology Lab first reported a position in OKUR in Q4 2023 and held it in 1 quarter. The position peaked at $20K in Q4 2023. 61 funds tracked by Wall St. Rank hold OKUR as of Q1 2024.

  • Dynamic Technology Lab reported no remaining OnKure Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,271 OnKure Therapeutics shares in Q1 2024, an estimated $20K.
  • Dynamic Technology Lab first reported a position in OnKure Therapeutics in Q4 2023 and held it in 1 quarter.
  • Dynamic Technology Lab's OnKure Therapeutics position peaked at $20K in Q4 2023.
  • 61 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.